Recent Updates
Recently added Catalysts
KYMR Positive Sentiment Score: 70/100

Kymera Therapeutics to Participate in Upcoming May Investor Conferences

Wednesday, May 8, 2024 1 min read
Key Takeaway: Kymera Therapeutics, a clinical-stage biopharmaceutical company, has announced its participation in two upcoming investor conferences. The events include the BofA Securities 2024 Health Care Conference in Las Vegas and the TD Cowen 5th Annual Oncology Innovation Virtual Summit. These appearances indicate the company's proactive approach to investor relations and its focus on advancing targeted protein degradation technologies. Live webcasts of the presentations will be available on their website, allowing broader access to their discussions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kymera Therapeutics is actively engaging with the investment community.
  • Participation in major conferences indicates growing recognition.
  • The company's innovative work in targeted protein degradation is highlighted.

Full Press Release Details

WATERTOWN, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at the following upcoming investor events:
BofA Securities 2024 Health Care Conference in Las Vegas, NV on May 15 at 4:20 p.m. PT; and
TD Cowen 5th Annual Oncology Innovation Virtual Summit on May 28 at 1:30 p.m. ET.
Live webcasts of the presentations will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. Replays of the webcasts will be archived and available following the events.
About Kymera Therapeutics
Investor and Media Contact:
Vice President, Investor Relations
investors@kymeratx.com

Tags

Targeted Protein Degradation

Frequently Asked Questions

When will Kymera participate in investor events?

Kymera will participate in the BofA Securities Conference on May 15 and the TD Cowen Summit on May 28.

Where can I watch Kymera's investor presentations?

Live webcasts of presentations will be available on Kymera's website under the Investors section.

What is the focus of Kymera Therapeutics?

Kymera Therapeutics specializes in advancing small molecule medicines through targeted protein degradation.

What times are the investor events scheduled?

The BofA event is on May 15 at 4:20 p.m. PT, and the TD Cowen event is on May 28 at 1:30 p.m. ET.

Will the webcasts be available after the events?

Yes, replays of the webcasts will be archived and accessible after the events.

Tags: KYMR Viatris Investor Conferences Healthcare Kymera Therapeutics targeted protein degradation investor conferences health care oncology innovation
Last updated: May 8, 2024